References
- Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature 2014;509:575-81
- Wilhelm M, Schlegl J, Hahne H, et al. Mass-spectrometry-based draft of the human proteome. Nature 2014;509:582-7
- Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science 2015;347:1260419
- The human protein atlas. Available from: www.proteinatlas.org
- Lindskog C, Fagerberg L, Hallstrom B, et al. The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling. FASEB J 2014;28:5184-96
- Kampf C, Mardinoglu A, Fagerberg L, et al. The human liver-specific proteome defined by transcriptomics and antibody-based profiling. FASEB J 2014;28:2901-14
- Haggmark A, Mikus M, Mohsenchian A, et al. Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis. Ann Clin Transl Neurol 2014;1:544-53
- Haggmark A, Hamsten C, Wiklundh E, et al. Proteomic profiling reveals autoimmune targets in sarcoidosis. Am J Respir Crit Care Med 2015;191:574-83
- Ponten F, Schwenk JM, Asplund A, Edqvist PH. The Human Protein Atlas as a proteomic resource for biomarker discovery. J Intern Med 2011;270:428-46
- Lindskog C, Korsgren O, Ponten F, et al. Novel pancreatic beta cell-specific proteins. antibody-based proteomics for identification of new biomarker candidates. J Proteomics 2012;75:2611-20
- Mardinoglu A, Agren R, Kampf C, et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun 2014;5:3083
- Edlund K, Lindskog C, Saito A, et al. CD99 is a novel prognostic stromal marker in non-small cell lung cancer. Int J Cancer 2012;131:2264-73
- Kumar A, Rao A, Bhavani S, et al. Automated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers. Proc Natl Acad Sci USA 2014;111:18249-54
- O’Hurley G, Sjostedt E, Rahman A, et al. Garbage in, garbage out. a critical evaluation of strategies used for validation of immunohistochemical biomarkers. Mol Oncol 2014;8:783-98
- Lindskog C, Edlund K, Mattsson JS, Micke P. Immunohistochemistry-based prognostic biomarkers in NSCLC. novel findings on the road to clinical use? Expert Rev Mol Diagn 2015;15(4):471-90
- Soderberg O, Leuchowius KJ, Gullberg M, et al. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 2008;45:227-32
- Witze ES, Old WM, Resing KA, Ahn NG. Mapping protein post-translational modifications with mass spectrometry. Nat Methods 2007;4:798-806
- Giesen C, Wang HA, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 2014;11:417-22